Morgan Stanley »

Lexaria Bioscience shares owned by Morgan Stanley

Quarter-by-quarter ownership of Lexaria Bioscience (LEXX) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Lexaria Bioscience

Tip: Access up to 7 years of quarterly data

All positions including Lexaria Bioscience held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexaria Bioscience by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-03-31 $85k 23k 3.63

More positions owned by Morgan Stanley

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Visa Com Cl A (V)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
Ishares Tr Core S&p500 Etf (IVV)
UnitedHealth (UNH)

View all positions for Morgan Stanley

Top funds holding Lexaria Bioscience

Invenomic Capital Management
Geode Capital Management
Vanguard Group
Raymond James Financial Services Advisors
State Street Corporation
ADAR1 Capital Management
Welch Group
Morgan Stanley
Northern Trust
Citadel Advisors
Wealth Enhancement Advisory Services
XTX Topco
Royal Bank of Canada
Oakworth Capital
Tower Research Capital

View all funds holding Lexaria Bioscience